Bailard »

Spero Therapeutics shares owned by Bailard

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Bailard

Quarter filed Position value Share count Share price at filing
2024-03-31 $105k 61k 1.72

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus 2000 Val Etf (IWN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Inf Tech Etf (VGT)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Gilead Sciences (GILD)
Amazon (AMZN)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Spero Therapeutics

Vanguard Group
ADAR1 Capital Management
Alphabet
Murchinson
Acadian Asset Management
Atlas Venture Life Science Advisors
BlackRock
Geode Capital Management
AWM Investment Company
Shay Capital
Man Group
Bridgeway Capital Management
Millennium Management
DAFNA Capital Management
Northern Trust

View all funds holding Spero Therapeutics